AbCellera Biologics (ABCL)
NASDAQ:ABCL
Holding ABCL?
Track your performance easily

AbCellera Biologics (ABCL) Income Statement

1,541 Followers

AbCellera Biologics Income Statement

Last quarter (Q2 2024), AbCellera Biologics's total revenue was $7.32M, an increase of 72722.20% from the same quarter last year. In Q2, AbCellera Biologics's net income was $-36.93M. See AbCellera Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 36.24M$ 38.02M$ 485.42K$ 375.20M$ 233.16M$ 11.61M
Cost of Revenue
---$ 45.52M$ 27.14M$ 0.00
Gross Profit
$ 36.24M$ 38.02M$ 485.42K$ 329.69M$ 206.01M$ 11.61M
Operating Expense
$ 303.88M$ 261.08M$ 268.91K$ 107.79M$ 41.66M$ 13.96M
Operating Income
$ -267.64M$ -230.43M$ 216.51K$ 221.90M$ 164.35M$ -2.34M
Net Non Operating Interest Income Expense
$ 41.91M$ 42.25M$ 12.03K$ -1.90M$ -6.22M$ -54.00K
Other Income Expense
$ -46.92M$ 6.78M$ -10.55K$ -855.00K$ -300.00K$ 186.00K
Pretax Income
$ -178.81M$ -174.03M$ 239.10K$ 219.15M$ 157.83M$ -2.21M
Tax Provision
$ -25.51M$ -27.63M$ 80.58K$ 65.69M$ 38.91M$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -153.30M$ -146.40M$ 158.52K$ 153.46M$ 85.10M$ -2.21M
Basic EPS
$ -0.53$ -0.51$ 0.56$ 0.56$ 0.53$ -0.01
Diluted EPS
$ -0.53$ -0.51$ 0.50$ 0.48$ 0.45$ -0.01
Basic Average Shares
$ 1.17B$ 289.17M$ 285.06M$ 275.76M$ 159.20M$ 172.38M
Diluted Average Shares
$ 1.17B$ 289.17M$ 314.83M$ 318.29M$ 263.13M$ 172.38M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 303.88M$ 261.08M$ 268.91K$ 153.30M$ 68.80M$ 13.96M
Net Income From Continuing And Discontinued Operation
$ -153.30M$ -146.40M$ 158.52K$ 153.46M$ 118.92M$ -2.21M
Normalized Income
$ -204.32M$ -201.66M$ 175.74K$ 154.06M$ 119.14M$ -2.40M
Interest Expense
---$ 5.22M$ 6.51M$ 209.00K
EBIT
$ -178.81M$ -174.03M$ 239.10K$ 224.37M$ 164.34M$ -2.00M
EBITDA
$ -117.49M$ -143.13M$ 272.20K$ 241.62M$ 169.62M$ -155.00K
Currency in USD

AbCellera Biologics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis